S3) Lipid and Cholesterol Metabolism Flashcards

1
Q

Describe the four pro-atherogenic effects of oxidised LDL

A
  • Inhibits macrophage motility
  • Induces T-cell activation and VSMC division / differentiation
  • Toxic to endothelial cells
  • Enhances platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the indications for statins?

A
  • CV risk prevention (CVD + DM)
  • Familial Hypercholesterolaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the three ways in which statins act as a lipid-lowering drug

A
  • Inhibit cholesterol synthesis in hepatocytes
  • Increase clearance of IDL and LDL
  • Decrease production of VLDL and LDL

→ Inhibit HMG - coA reductase so reduced conc of cholesterol in cell → low intracellular cholesterol stimulates synthesis of LDL receptor → more LDL uptake from blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the possible adverse reactions of statin drug treatment?

A
  • Increased transaminase levels – rapidly reversible, no evidence of chronic liver disease
  • Myopathy – seen when higher doses of statins are used in combination with other drugs, rarely rhabdomyolysis
  • Miscellaneous – GI complaints, arthralgias, and headaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify four secondary benefits of statin treatment

A
  • Anti-inflammatory
  • Plaque reduction
  • Improved endothelial cell function
  • Reduced thrombotic risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the structure and function of fibric acid derivatives

A
  • Structure: ampipathic carboxylic acids
  • Function:

I. PPARα agonist – increases production of lipoprotein lipase

II. Reduces triglyceride production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are two common fabric aid derivatives

A

fenofibrate and gemfibrozil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the indications for fibric acid derivatives?

A
  • Adjunctive therapy to diet
  • Hypertriglyceridemia
  • Combined hyperlipidemia with low HDL (do not respond to NA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the contraindications for fibric acid derivatives?

A
  • Hepatic or renal dysfunction
  • Pre-existing gallbladder disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the possible adverse effects of fibric acid derivatives?

A
  • GI upset
  • Cholelithiasis
  • Myositis
  • Abnormal LFTs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the three ways in which nicotinic acid acts as a lipid-lowering drug

A
  • Reduces VLDL and increases HDL at high doses
  • Lipid lowering effect by inhibition of lipoprotein synthesis

– inhibits adipose tissue to release fatty acids

  • Reduces coronary events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the possible adverse effects of nicotinic acid?

A
  • Flushing, itching, headache
  • Hepatotoxicity
  • Activation of peptic ulcer
  • Hyperglycemia and reduced insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the contraindications of nicotinic acid?

A
  • Active liver disease
  • Unexplained LFT elevations
  • Peptic ulcer disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the three ways in which ezetimibe acts as a lipid-lowering drug

A

Ezetimibe selectively inhibits intestinal cholesterol absorption:

  • ↓ intestinal delivery of cholesterol to the liver
  • ↑ expression of hepatic LDL receptors
  • ↓ cholesterol content of atherogenic particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the possible adverse effects of ezetimibe

A
  • Headache
  • Abdominal pain
  • Diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe how lipid lowering drugs can be used in combination therapy

A

Statin plus:

  • Fibrate (not gemfibrozil)
  • Nicotinic acid
  • Ezetimibe
  • Omega-3 fatty acids
  • Resins
17
Q

What should one consider when assessing the use combination therapy of lipid lowering drugs

A
  • Benefit (CV risk reduction)
  • Cost
  • ADRs
18
Q

In three steps, explain why gemfibrozil is not the fibrate of choice in combination fibrate + statin therapy

A

Fibrate + statin therapy may significantly improve triglyceride, LDL-C, and HDL-C levels

⇒ However, fibrates + statins are associated with increased risk for myopathy and rhabdomyolysis

Gemfibrozil may impair glucuronidation of statins

19
Q

Complete the table by indicating whether the drug increases/decreases or does not affect the listed lipid parameter

A
20
Q

Provide two examples of a lipid-lowering drug

A
  • Simvastatin: prodrug that is activated by first pass metabolism
  • Atorvastatin
21
Q

which factors increase levels of statins in the body

A

→ CYP3A4 breaks down statin

→ amiodarone, macrolides, grapefruit all inhibit CYP3A4 so reduction in the breakdown of statin

22
Q

Cholesterol break down

A
  • mainly synthesised in body (25% from diet)
  • important for membrane integrity, involved in steroid hormones, bile acids and vitamin D
  • LDL susceptible to oxidative reactions → atheroma plaques
  • HDL carries cholesterol from blood → tissues (good cholesterol) to liver
  • triglycerides transport cholesterol from HDL→VLDL
23
Q

when can fatty acid streaks start to occur

A
  • at any age
    *
24
Q

how can statins cause an antinflammatory effect

A
  • reduced proliferation of anti-inflammatory cells into plaque, plasma, CRP, adhesion molecules and cytokines
25
Q

how can statins cause improved plaque conc

A

increases collagen and increases SMC

26
Q

how do statins improve vascular endothelial function?

A
  • increase NO and vascular endothelium growth factor (VEGF)
  • decrease in endothelin so reduced vasoconstriction
27
Q

how do statins improve haemostasis

A
  • reduced plasma fibrinogen and platelet aggregation
  • increase in fibrinolysis
28
Q

how do statins act as an antioxidant

A

reduce superoxide formation

29
Q

who should you avoid giving statins to?

A
  • people with renal/hepatic impairments
  • pregnant/breastfeeding → cholesterol is important in development of a baby
30
Q

what is a big side effect of statins you should be aware of

A

rhabdomyolysis:

if they complain of muscle aches and pains in arms check for CK levels

so if this is the case can prescribe them some ezetimibe

31
Q

Ezetimibe few ADR

A

prodrug that undergoes hepatic metabolism so undergoes significant enterohepatic circulation so most ADRS are related to the GI tract

32
Q

statin doses for primary prevention

A

CVD risk > 10%

20mg atorvastatin

33
Q

if someone has had a stroke or heart attack how much statin do you prescribe

A

80mg atorvastatin to prevent another stroke

34
Q

when is simvastatin taken

A
  1. Most cholesterol production occurs during night, So it has a greater effect at reducing levels at night
  2. It has a short half life, during night there is less interference with elimination and metabolism so might have a longer lasting effect
35
Q

PCSK9 inhibitors

A

→ PCSK9 binds to LDL receptors on liver cells, leading to the destruction of the receptors and a reduction in the liver’s ability to clear LDL cholesterol from the bloodstream.

→ inhibitors will increase the number of LDL receptors and so increase elimination of LDL receptors

→ effective in patients already taking statins and very effective in reducing LDL

36
Q

what are some examples of PCSK9 Inhibitors

A

‘mab’

→ Alirocumab

→ evolocumab

37
Q

how does Inclisiran work

A

SiRNA that reduces the synthesis of PCSK9

38
Q

what are some common side effects of statins

A

Asthenia: abnormal physical weakness or lack of energy
Gastrointestinal disturbance and headache are very common, particularly on starting treatment.
Myositis is rare, and reversible but significant a rare group of diseases characterized by inflamed muscles, which can cause prolonged muscle fatigue and weakness

39
Q

what are some secondary causes of hypercholesterolaemia

A